SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 598 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43,375,105 | -35.2% | 203,633 | -41.5% | 0.04% | -34.8% |
Q2 2023 | $66,964,715 | -5.6% | 348,265 | -0.3% | 0.07% | -18.8% |
Q1 2023 | $70,915,315 | +68.9% | 349,289 | +5.3% | 0.08% | +77.1% |
Q4 2022 | $41,986,941 | +137.3% | 331,784 | +157.0% | 0.05% | +65.5% |
Q3 2022 | $17,695,000 | +76.5% | 129,099 | +128.6% | 0.03% | +107.1% |
Q2 2022 | $10,024,000 | +11.3% | 56,483 | -9.8% | 0.01% | +27.3% |
Q1 2022 | $9,005,000 | -52.3% | 62,600 | -48.6% | 0.01% | -35.3% |
Q4 2021 | $18,877,000 | +131.6% | 121,885 | +152.5% | 0.02% | +112.5% |
Q3 2021 | $8,150,000 | +19.0% | 48,276 | +11.5% | 0.01% | +14.3% |
Q2 2021 | $6,851,000 | +49.6% | 43,281 | +30.9% | 0.01% | +40.0% |
Q1 2021 | $4,581,000 | -16.9% | 33,053 | +6.5% | 0.01% | -28.6% |
Q4 2020 | $5,512,000 | – | 31,047 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |